Tower Research Capital LLC (Trc) Innate Pharma Sa Put Options Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IPHA
# of Institutions
10Shares Held
96.7KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY43.5KShares$81,8250.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il24.3KShares$45,6210.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny15.3KShares$28,8120.0% of portfolio
-
Ubs Group Ag9KShares$16,9210.0% of portfolio
-
Gamma Investing LLC Foster City, CA3.46KShares$6,4970.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $150M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...